Multidisciplinary scientist, with interests that include the application of physics and chemistry toward investigation of challenging biological questions. His knowledge of advanced physical techniques enables characterisation of material properties, as well as investigation of biophysical and biological interactions of such materials for potential medical and industrial applications. His research has led to international publications, book chapters, successful grant applications resulting in commercialisation and the generation of IP, patents and license agreements.

Research interests include responsive biomaterials, nanomaterials, surface modification, surface biointeractions and characterisation using state of the art techniques such as Neutron Reflectivity, SANS, AFM, TEM, FTIR and ellipsometry. He has several years of experience in single chain phosphocholine biosurfactants, tissue engineering and protein interactions. Other interests include biological interactions of nanoparticles, proteins, cells, bacteria and more recently the development of engineered polypeptides, carbon nanotubes and bio graphene for biomedical application. 

My current research activities

• The development of novel drug delivery agents

• Synthesis and application of nanomaterials in biomedical, environmental and energy applications

• Synthesis and characterisation of bio surfactants and smart responsive polymer systems

• Synthesis and development of novel biomaterials

• Alkyl phosphocholine as novel drugs for parasitic infections, (trypanosome), antimicrobial agent and cell differentiation control.  

• Peptide drugs for antimicrobial and cell proliferation

• Surface modification for controlled  interactions of proteins, cells and engineered polymer

My future research direction is toward the development of multidisciplinary research at the interface of physics, chemistry and biology. More specifically the desire is toward development of advanced multifunctional materials for biomedical, environmental and energy applications.  

Companies that utilise nanomaterials, biomaterials and controlled drug delivery application, these include;

• Syngenta

• Unilever

• Thermo Scientific

Organisations of interest include those that would enhance collaborative advancement in mutually favourable research and knowledge transfer leading

These may include universities, scientific societies and government contact 

Innovative product development, commercialisation and IP generation